ENOS MOSS: Open Payments
NPI 1548527997 · BRENTWOOD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,531 in 208 payments from 20 companies in 2025. Trend: 2023 $79 · 2024 $1,578 · 2025 $3,531
Food & beverage: $3,531
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 38 | $628 |
| ABBVIE INC. | 26 | $500 |
| Corium, LLC | 27 | $477 |
| Otsuka America Pharmaceutical, Inc. | 16 | $243 |
| Collegium Pharmaceutical, Inc. | 11 | $236 |
| Axsome Therapeutics, Inc. | 15 | $210 |
| Neurocrine BioSciences, Inc. | 16 | $205 |
| Alkermes, Inc. | 10 | $201 |
| Teva Pharmaceuticals USA, Inc. | 5 | $184 |
| Tris Pharma Inc | 15 | $152 |
Products named: CAPLYTA, VRAYLAR, Azstarys, REXULTI, Jornay PM, Auvelity, INGREZZA, ARISTADA.
Industry payments across MO — which companies pay providers there.
